Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Not yet recruiting × Rectal Neoplasms × Specimen Handling × Clear all

Status

Recruiting 5 Active not recruiting 3 Withdrawn 1 Terminated 1 Completed 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Carcinoma, Renal Cell 7 Prostatic Neoplasms 5 Lymphoma, T-Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Glioblastoma 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mouth Neoplasms 2 Leukemia, Biphenotypic, Acute 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Colorectal Neoplasms 2 Carcinoma 2 Anatomic Stage I Breast Cancer AJCC v8 2 Waldenstrom Macroglobulinemia 1 Thrombocytosis 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Capecitabine 14 Oxaliplatin 13 Radiotherapy 7 Surgical Procedures, Operative 5 Fluorouracil 5 Drug Therapy 5 tislelizumab 4 Irinotecan 4 sintilimab 3 Neoadjuvant Therapy 3 Immunotherapy 3 Endoscopic Mucosal Resection 3 Bevacizumab 3 raltitrexed 2 XELOX 2 Immune Checkpoint Inhibitors 2 FOLFOXIRI protocol 2 trifluridine tipiracil drug combination 1 toripalimab 1 sperm releasing substance 1 spartalizumab 1 saxagliptin 1 s-formylglutathione hydrolase 1 envafolimab 1 disitamab vedotin 1 cemiplimab 1 camrelizumab 1 Water 1 Trinitrotoluene 1 Trifluridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡